MedCaT: what changed
Two fiscal years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
MedCaT
Largest movements
- Receivables within one year +€46,100
up €46,100 (+530.4%), from €8,692 to €54,792
of which Other amounts receivable: +€43,230
- Cash -€35,354
down €35,354 (-51.6%), from €68,469 to €33,116
mainly Receivables within one year (-€46,100) and Other debts (-€4,320)
- Trade debts +€8,068
up €8,068 (+1106.2%), from €729 to €8,798
- Reserves +€5,880
up €5,880 (+10.9%), from €53,770 to €59,650
- Other debts -€4,320
down €4,320 (-100.0%), from €4,320 to €0
- Tax, wage and social debts +€1,018
new in 2025: €1,018
- Gross operating margin +€1,477
up €1,477 (+23.7%), from €6,238 to €7,715
- Financial income +€898
up €898 (+3978.6%), from €23 to €920
- Taxes +€700
up €700 (+53.1%), from €1,318 to €2,018
- Financial charges -€128
down €128 (-27.7%), from €462 to €334
- Other operating charges -€125
down €125 (-23.6%), from €528 to €403
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Cash bridge derived
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €77,420 | €88,066 | +€10,646 | +13.8% |
| Current assets | 29/58 | €77,420 | €88,066 | +€10,646 | +13.8% |
| Stocks and contracts in progress | 3 | €0 | - | = | |
| Stocks | 30/36 | €0 | - | = | |
| Amounts receivable within one year | 40/41 | €8,692 | €54,792 | +€46,100 | +530.4% |
| Trade receivables | 40 | €7,329 | €10,199 | +€2,870 | +39.2% |
| Other amounts receivable | 41 | €1,364 | €44,593 | +€43,230 | +3169.9% |
| Cash at bank and in hand | 54/58 | €68,469 | €33,116 | -€35,354 | -51.6% |
| Deferred charges and accrued income | 490/1 | €258 | €158 | -€100 | -38.8% |
| Total equity and liabilities | 10/49 | €77,420 | €88,066 | +€10,646 | +13.8% |
| Equity | 10/15 | €72,370 | €78,250 | +€5,880 | +8.1% |
| Contributions | 10/11 | €18,600 | €18,600 | = | 0.0% |
| Reserves | 13 | €53,770 | €59,650 | +€5,880 | +10.9% |
| Distributable reserves | 133 | €53,770 | €59,650 | +€5,880 | +10.9% |
| Amounts payable | 17/49 | €5,050 | €9,816 | +€4,766 | +94.4% |
| Amounts payable within one year | 42/48 | €5,050 | €9,816 | +€4,766 | +94.4% |
| Trade debts | 44 | €729 | €8,798 | +€8,068 | +1106.2% |
| Suppliers | 440/4 | €729 | €8,798 | +€8,068 | +1106.2% |
| Taxes, remuneration and social security | 45 | - | €1,018 | +€1,018 | |
| Taxes | 450/3 | - | €1,018 | +€1,018 | |
| Other amounts payable | 47/48 | €4,320 | €0 | -€4,320 | -100.0% |
| Accrued charges and deferred income | 492/3 | €0 | - | = | |
| Other operating charges | 640/8 | €528 | €403 | -€125 | -23.6% |
| Gross operating margin | 9900 | €6,238 | €7,715 | +€1,477 | +23.7% |
| Operating profit (loss) | 9901 | €5,711 | €7,312 | +€1,601 | +28.0% |
| Financial income | 75/76B | €23 | €920 | +€898 | +3978.6% |
| Recurring financial income | 75 | €23 | €920 | +€898 | +3978.6% |
| Financial charges | 65/66B | €462 | €334 | -€128 | -27.7% |
| Recurring financial charges | 65 | €462 | €334 | -€128 | -27.7% |
| Profit (loss) for the period before taxes | 9903 | €5,271 | €7,898 | +€2,627 | +49.8% |
| Income taxes | 67/77 | €1,318 | €2,018 | +€700 | +53.1% |
| Profit (loss) for the period | 9904 | €3,953 | €5,880 | +€1,927 | +48.7% |
| Profit (loss) for the period to be appropriated | 9905 | €3,953 | €5,880 | +€1,927 | +48.7% |
Source: filed annual accounts (NBB), fiscal years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 30 September 2026 via checked.be.